BioAtla (NASDAQ:BCAB) Stock Quotes, Forecast and News Summary

Q: What sector and industry does BioAtla (BCAB) operate in?

BioAtla is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

BioAtla Stock (NASDAQ: BCAB) stock price, news, charts, stock research, profile.

Open	$1.34
Close	$1.43
Volume / Avg.	825.80K / 825.90K
Day Range	1.29 - 1.45
52 Wk Range	1.24 - 4.02
Market Cap	$69.28M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	41
Short Interest	12.62%
Days to Cover	11.04

Recent News

Around $2M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying

The Dow Jones index closed higher by around 250 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Avi Kapoor

Around $1.5M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying

The Dow Jones closed higher by more than 100 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Lisa Levin

Dow Rises Over 100 Points; Rayonier Advanced Materials Shares Plunge

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 100 points on Tuesday. The Dow traded up 0.40% to 33,653.27 while the NASDAQ rose 0.83% to 10,724.37. The S&P 500 also rose, gaining, 0.55% to 3,913.66.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Mar

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About BioAtla Inc

Sector

Health Care

Industry

Biotechnology

BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy BioAtla (BCAB) stock?

You can purchase shares of BioAtla (NASDAQ:BCAB) through any online brokerage.

View our list of the best stock brokerages

Who are BioAtla (BCAB) competitors?

Other companies in BioAtla’s space includes: Serina Therapeutics (AMEX:SER), HOOKIPA Pharma (NASDAQ:HOOK), Intensity Therapeutics (NASDAQ:INTS), CARISMA Therapeutics (NASDAQ:CARM) and Burning Rock Biotech (NASDAQ:BNR).

What is the target price for BioAtla (BCAB) stock?

There is no analysis for BioAtla.

What is the forecast for BioAtla (BCAB) stock?

BioAtla has a consensus price target of $13.14.

Current stock price for BioAtla (BCAB)?

The stock price for BioAtla (NASDAQ: BCAB) is $1.4398 last updated July 3, 2024 at 3:35 PM EDT.

Does BioAtla (BCAB) pay a dividend?

There are no upcoming dividends for BioAtla.

When is BioAtla (NASDAQ:BCAB) reporting earnings?

BioAtla’s Q2 earnings are confirmed for Tuesday, July 30, 2024.

Is BioAtla (BCAB) going to split?

There is no upcoming split for BioAtla.

What sector and industry does BioAtla (BCAB) operate in?

BioAtla is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

BioAtla

BioAtla (BCAB) Forecast